Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fbarreto
    Member
    • Jan 2010
    • 15

    #1

    Re-assembly of singletons?

    Hi, all

    I have 454 transcriptome data, and I am a bit puzzled by some assemblies I have been doing. When I did a first assembly (on CLC Workbench), the ~600,000 reads assembled into 13,000 contigs and 157,000 singletons. Just out of curiosity, I used the set of singletons and did a new assembly of them. Since they were supposedly unmatched reads, I expected them to not assemble very well, if at all. Instead, the singletons assembled into a new set of 14,000 contigs, leaving a remaining 70,000 singletons!! I used the same stringency for both assemblies (0.5 length fraction, and 0.90 identity).

    When I look at the coverage for the re-assembled singletons, it seems they have comparable coverage and length distribution to the original assembly. So they seem to be OK.

    I guess I don't really understand the assembly algorithm, cause I am a bit puzzled as to why it would leave so many reads unassembled in a first pass, when they were obviously matched to other reads.

    So my question is: is re-assembly of 'left-over' singletons from a first assembly a reasonable approach? Or does that somehow force 'bad' contigs to be formed?

    Any insight would be extremely helpful, since the structure of my dataset will vary tremendously depending on the answer!

    Thanks!

    Felipe
  • cnavarro
    Junior Member
    • Jul 2011
    • 1

    #2
    the same concern...

    Comment

    • sklages
      Senior Member
      • May 2008
      • 628

      #3
      Keep in mind that CLC GWB is not a transcriptome but a genome assembler. That might lead to unforseen results. You may want to ask CLC support tocomment on the results you have gotten.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:52 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Working...